Here’s the Worst, Anti-Science Idea of the Week from the Republican Congress

The head of the House science committee is pissed about research into Monsanto’s Roundup herbicide.

House Science Committee Chairman Rep. Lamar Smith, (R-Texas) . Charles Dharapak/Associated Press

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

At a hearing this week, Rep. Lamar Smith (R.-Texas) lashed out at the International Agency for Research on Cancer (IARC), the group that assesses cancer risk for the UN’s World Health Organization. He accused it of conducting “cherry-picked science,” which, he declared “raises questions about why IARC should receive any [US] government funding in the future.”

“Cherry-picked science” is quite a charge coming from Smith, a magnate for cash from the fossil fuel and agribusiness industries who is widely regarded as the “preeminent climate change denier in Congress,” to use the veteran Los Angeles Times reporter Michael Hiltzik’s phrase.

What drew Smith’s ire is an ongoing dispute over the herbicide glyphosate, marketed by Monsanto as Roundup. In an assessment of the scientific literature back in 2015, IARC declared glyphosate “probably carcinogenic to humans.” The finding triggered a fierce pushback from Monsanto as well as a flood of pending lawsuits from cancer survivors

Controversy has roiled around the assessment ever since. Last June, Reuters reported that the agency had failed to consider relevant unpublished data from a study suggesting glyphosate doesn’t cause cancer. The IARC responded that its policy is to never consider unpublished studies in its assessment, and it has since fiercely defended is conclusion.  

Some scientists defend the IARC’s position, such as the 100 US and worldwide researchers who signed this 2016 paper in the Journal of Epidemiological Community Health. Others authorities dispute it, including the US Environmental Protection Agency and its counterpart across the Atlantic, the European Food Safety Agency, both of which have declared glyphosate not likely to be carcinogenic. 

In other words, there is genuine scientific disagreement about whether glyphosate poses a cancer risk. In an ideal world, the views of a science-denying zealot like Lamar Smith would have little bearing on the debate. In reality, he’s a powerful figure in a party that controls Congress and the White House. And he chairs the US House’s Science, Space, and Technology Committee, a spot he will hold until he retires at the end of his term in 2019.

But even if Congress slashes US financial support for the IARC, it won’t likely have a huge effect on its funding. According to a 2017 Reuters piece, the agency’s budget is just $34 million per year, and the United States has contributed just $40 million to it since 1992—which amounts to roughly $1.6 million a year, or less than 5 percent of IARC’s annual budget. 

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate